Business Description
Specialized Medical Co
ISIN : SA16B0CHUPH2
Description
Specialized Medical Co is a full-service healthcare provider, offering a broad range of specialized medical services that encompass the entire healthcare value chain. The healthcare services provided by the company include ambulance services, cardiology, internal medicine, family medicine, and pediatrics. The company also offers surgical services, including general surgery, orthopedics, otorhinolaryngology, gynecological procedures, spinal surgery, obesity surgeries, and all general and specialized surgeries, supported by an integrated network of ancillary departments such as laboratories, diagnostic radiology, nuclear medicine services, anesthesia departments, internal pharmacies, physical therapy services, and nutritional consultations.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.81 | |||||
Debt-to-EBITDA | 1.97 | |||||
Interest Coverage | 4.96 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.66 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 5.75 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.31 | |||||
9-Day RSI | 21.32 | |||||
14-Day RSI | 26.95 | |||||
3-1 Month Momentum % | -9.66 | |||||
6-1 Month Momentum % | -9.24 | |||||
12-1 Month Momentum % | -19.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.1 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 9.23 | |||||
Days Sales Outstanding | 109.55 | |||||
Days Payable | 34.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2 | |||||
Forward Dividend Yield % | 2 | |||||
5-Year Yield-on-Cost % | 2 | |||||
Shareholder Yield % | 1.79 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 24.48 | |||||
Operating Margin % | 15.72 | |||||
Net Margin % | 17.36 | |||||
EBITDA Margin % | 27.1 | |||||
FCF Margin % | 12.89 | |||||
OCF Margin % | 18.56 | |||||
ROE % | 25.29 | |||||
ROA % | 11.56 | |||||
ROIC % | 11.64 | |||||
ROC (Joel Greenblatt) % | 17.78 | |||||
ROCE % | 19.04 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.8 | |||||
Forward PE Ratio | 16 | |||||
PE Ratio without NRI | 14.8 | |||||
PS Ratio | 2.55 | |||||
PB Ratio | 3.89 | |||||
Price-to-Tangible-Book | 3.88 | |||||
Price-to-Free-Cash-Flow | 19.83 | |||||
Price-to-Operating-Cash-Flow | 13.75 | |||||
EV-to-EBIT | 14.42 | |||||
EV-to-EBITDA | 11.12 | |||||
EV-to-Revenue | 3.01 | |||||
EV-to-FCF | 23.6 | |||||
Price-to-Graham-Number | 1.6 | |||||
Earnings Yield (Greenblatt) % | 6.94 | |||||
FCF Yield % | 5.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Specialized Medical Co Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 1,550.235 | ||
| EPS (TTM) (ï·¼) | 1.07 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 28.09 | ||
| 14-Day RSI | 26.95 | ||
| 14-Day ATR (ï·¼) | 0.213278 | ||
| 20-Day SMA (ï·¼) | 16.4575 | ||
| 12-1 Month Momentum % | -19.49 | ||
| 52-Week Range (ï·¼) | 15.75 - 21.69 | ||
| Shares Outstanding (Mil) | 250 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Specialized Medical Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Specialized Medical Co Stock Events
| Event | Date | Price (ï·¼) | ||
|---|---|---|---|---|
| SAR 0.320000 Cash Dividend | 2026-05-18 | 17.00 (-0.29%) | ||
| SAR 0.800000 Cash Dividend | 2026-01-07 | 18.04 (-0.55%) |
Show
Entries
Specialized Medical Co Frequently Asked Questions
What is Specialized Medical Co(SAU:4019)'s stock price today?
The current price of SAU:4019 is ï·¼15.84. The 52 week high of SAU:4019 is ï·¼21.69 and 52 week low is ï·¼15.75.
When is next earnings date of Specialized Medical Co(SAU:4019)?
The next earnings date of Specialized Medical Co(SAU:4019) is .
Does Specialized Medical Co(SAU:4019) pay dividends? If so, how much?
The Dividend Yield %  of Specialized Medical Co(SAU:4019) is 2% (As of Today), Highest Dividend Payout Ratio of Specialized Medical Co(SAU:4019) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Specialized Medical Co(SAU:4019) is 2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Specialized Medical Co
No articles.